Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended				6 Months Ended		12 Months Ended
	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019
Cash flows from operating activities:
Net loss	$ 582,091	$ (4,657,894)	$ (1,189,110)	$ (976,063)	$ (4,075,803)	$ (2,165,173)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Amortization of debt discount and deferred finance costs					1,283,691	28,065
Amortization of intangible assets	12,841		12,841		163,403	25,737
Stock-based compensation					2,147,591	340,674
Depreciation on development equipment					18,658
Issuance of common stock in lieu of cash for services						418,136
Change in fair value of derivative	(746,809)				(10,512)		$ (870,268)
Loss on debt conversion	41,469				166,067
Changes in operating assets and liabilities:
Prepaid expenses and other current assets					68,920	(14,967)
Accounts payable and accrued expenses					454,301	118,566
Accounts payable to related party					42,623	355,733
Net cash provided by (used in) operating activities					258,939	(893,229)
Cash flows from investing activities:
Cash acquired in mergers						182,883
Net cash provided by investing activities						182,883
Cash flows from financing activities:
Proceeds from sales of common stock						83,120
Proceeds from Payroll Protection Plan					250,000
Proceeds from short term loan, related party					70,000	709,000
Net cash provided by financing activities					320,000	792,120
Net increase in cash					578,939	81,774
Cash - beginning of period		$ 81,964		$ 2,498	81,964	2,498	2,498
Cash - end of period	$ 660,903		$ 84,272		660,903	84,272	$ 81,964
Non cash investing and financing activities:
Common shares issued upon partial conversion of debt					824,504
Recapitalization under reverse merger						3,727,752
Beneficial Conversion Feature on convertible debt and restricted common shares						509,140
Common stock issued for settlement of accounts payable						$ 238,090